Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
innovation publishing date : 2022 - 06 - 06 save search
AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
therapeutics asco phase 2
Cisco Unveils Innovations Driving New Security Cloud Strategy
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
CSCO | News | $48.1 0.65% 0.64% 13M
|
Technology Services
|
| O: 0.78%
H: 1.07%
C: -0.6%
security cloud
Professional Development Market Size in the US to Grow by USD 3.75 billion | Innovations in Technology to Drive Growth | Technavio
Published: 2022-06-06 (Crawled : 12:20) - prnewswire.com
ADBE M | $472.91 -0.33% -0.33% 2.4M
|
Technology Services
|
| O: 1.28%
H: 0.55%
C: -1.86%
technology growth market
Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention to Discuss Recent Updates to Ongoing Clinical Programs
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
TLSA | $0.6199 20.84% 17.24% 1.5M
|
Health Technology
|
| O: -2.78%
H: 3.9%
C: -3.16%
ongoing sciences life innovation
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BRKR | News | $78.56 -5.28% -5.58% 2.2M
|
Health Technology
|
| O: 0.09%
H: 0.44%
C: -0.77%
imaging
Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2022-06-06 (Crawled : 01:00) - prnewswire.com
SANA | $7.74 -6.3% -6.72% 1.9M
|
|
| O: 5.56%
H: 2.46%
C: -13.16%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
treatment drug application
Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-06-06 (Crawled : 01:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ibi351
Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-06-06 (Crawled : 01:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ibi110 antibody
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.